• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Kazakhstan Power Report Q1 2013 - Product Image

Kazakhstan Power Report Q1 2013

  • ID: 2384522
  • January 2013
  • Region: Kazakhstan
  • 45 pages
  • Business Monitor International

FEATURED COMPANIES

  • Bumimedic
  • Eli Lilly Malaysia
  • Hovid
  • Local Companies
  • Multinational Companies
  • Pfizer
  • MORE

BMI View:

Demand growth is healthy, reflecting economic expansion. Plans for new generating capacity continue to focus on conventional thermal sources, with gas taking the lead thanks to the state's substantial domestic resources. Asian influence is growing, with China and South Korea entering the power arena as financiers of and contractors for generating facilities. However, Russia may emerge as the partner of choice if Kazakhstan opts to bring nuclear capacity online.

In spite of Kazakhstan's vast gas reserves, the country's power industry is seeking to avoid overdependence on the fuel in electricity generation and has a diversified policy involving coal,
hydropower and renewables. Nuclear has been side-lined, but may well emerge as a key component of the power portfolio over the long term, thanks to huge uranium wealth. System losses are considerable and improved efficiency could narrow the supply/demand gap. Ongoing high level investment in generation,
transmission and distribution infrastructure is therefore necessary, and foreign partners, largely from Asia and Russia, are being lined up for the major projects.

The key trends and developments in the READ MORE >

FEATURED COMPANIES

  • Bumimedic
  • Eli Lilly Malaysia
  • Hovid
  • Local Companies
  • Multinational Companies
  • Pfizer
  • MORE

BMI Industry View 5

SWOT Analysis 7

Kazakhstan Power SWOT 7

Regional Overview 8

Industry Forecast Scenario 13

Kazakhstan Snapshot (Macro) 13
Table: Country Snapshot: Economic And Demographic Data 13
Table: Country Snapshot: Power Sector 13

Kazakhstan Forecast Scenario 14

Electricity Generation And Power Generating Capacity 14
Table: Kazakhstan Total Electricity Generation Data And Forecasts, 2010-2017 14
Table: Kazakhstan Total Electricity Generation Long-Term Forecasts, 2014-2021 16
Table: Kazakhstan Electricity Generating Capacity Data And Forecasts, 2010-2017 18
Table: Kazakhstan Electricity Generating Capacity Long-Term Forecasts, 2014-2021 19

Electricity Consumption 23
Table: Kazakhstan Total Electricity Consumption Data And Forecasts, 2010-2017 23
Table: Kazakhstan Total Electricity Consumption Long-Term Forecasts, 2014-2021 24

Transmission And Distribution, Imports And Exports 25
Table: Kazakhstan Electric Power Transmission And Distribution Losses Data And Forecasts, 2010-2017 25
Table: Kazakhstan Electric Power Transmission And Distribution Losses Long-Term Forecasts, 2014-2021 25
Table: Kazakhstan Trade Data And Forecasts, 2010-2017 25
Table: Kazakhstan Trade Long-Term Forecasts, 2014-2021 25

Key Policies/Market Structure 27

Regulation And Competition 27

Pricing 27
Table: Electricity Prices In The EU Member States, As Of May 2012 28

Key Projects Database 29
Table: Kazakhstan Major Projects - Power 29

Risk/Reward Ratings 31

Central And Eastern Europe Regional Power Risk/Reward Ratings 31
Table: Central And Eastern Europe Power Risk/Reward Ratings 34

Kazakhstan's Power Risk/Reward Ratings 34

Rewards 34

Risks 35

Competitive Landscape 36

KEGOC 36

AES 37

Glossary of Terms 38
Table: Glossary of Terms 38

Methodology And Sources 39

Industry Forecasts 39

Power Industry - Data Methodology 40

Generation and Consumption Data 40

Electricity Generation Capacity Data 41

Power Risk/Reward Ratings Methodology 41
Table: Power Risk/Reward Indicators 43

Sources 44

Company Profiles
Local Companies
Pharmaniaga
Prime Pharmaceutical
Bumimedic
Hovid
Chemical Company of Malaysia
Kotra Pharma
Multinational Companies
GlaxoSmithKline
Pfizer
Novartis
Merck & Co
Sanofi
Eli Lilly Malaysia
Ranbaxy Malaysia

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos